Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Has $795,000 Stock Holdings in Procter & Gamble Company (The) $PG

Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group reduced its position in Procter & Gamble Company (The) (NYSE:PGFree Report) by 25.6% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 4,990 shares of the company’s stock after selling 1,721 shares during the period. Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group’s holdings in Procter & Gamble were worth $795,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Kingstone Capital Partners Texas LLC raised its holdings in Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after acquiring an additional 76,017,350 shares during the period. Nuveen LLC bought a new position in shares of Procter & Gamble during the first quarter worth approximately $1,954,941,000. Price T Rowe Associates Inc. MD increased its stake in shares of Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the period. Invesco Ltd. lifted its holdings in Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares during the last quarter. Finally, Valeo Financial Advisors LLC boosted its stake in Procter & Gamble by 1,875.5% in the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after purchasing an additional 1,674,139 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Jennifer L. Davis sold 3,227 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $491,246.21. Following the sale, the chief executive officer directly owned 61,764 shares of the company’s stock, valued at approximately $9,402,333.72. The trade was a 4.97% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Balaji Purushothaman sold 490 shares of the stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $74,592.70. Following the completion of the transaction, the insider directly owned 12,616 shares of the company’s stock, valued at approximately $1,920,533.68. The trade was a 3.74% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 149,763 shares of company stock valued at $23,421,279 over the last ninety days. 0.20% of the stock is owned by insiders.

Wall Street Analyst Weigh In

PG has been the subject of a number of research reports. BNP Paribas reissued an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a report on Friday, August 15th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Procter & Gamble in a research note on Saturday. Evercore ISI restated an “in-line” rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Raymond James Financial dropped their price target on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating for the company in a research report on Monday, October 20th. Finally, Berenberg Bank boosted their price target on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research note on Wednesday, September 17th. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $171.68.

Check Out Our Latest Research Report on PG

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $152.62 on Monday. The company has a current ratio of 0.71, a quick ratio of 0.51 and a debt-to-equity ratio of 0.45. The stock has a market capitalization of $357.21 billion, a PE ratio of 22.28, a PEG ratio of 4.05 and a beta of 0.36. The firm has a 50 day moving average of $154.66 and a 200-day moving average of $158.38. Procter & Gamble Company has a 12 month low of $146.96 and a 12 month high of $180.43.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.51%. The business had revenue of $22.39 billion for the quarter, compared to analysts’ expectations of $22.23 billion. During the same period last year, the firm posted $1.93 earnings per share. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. On average, equities research analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be given a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. The ex-dividend date is Friday, October 24th. Procter & Gamble’s dividend payout ratio is currently 64.98%.

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.